Healthians

Healthians is an Indian health-technology and diagnostics company focused on making medical testing available through home sample collection. The company was incorporated in 2015 as a subsidiary of Expedient Healthcare and was founded by Deepak Sahni. Its operating model connects consumers with diagnostic services through an online platform, while trained personnel collect specimens at customers’ homes and route them to laboratories for testing. This model is designed to reduce the need for patients to travel to diagnostic centres and to make routine health screening more convenient. The company established its first laboratory in Gurugram and subsequently developed a wider laboratory and collection network in India. The available reference material describes Healthians as operating in more than 250 cities and having a network of 20 laboratories across the country. Its service portfolio is associated with routine pathology and preventive-health testing, although the available material does not provide a complete catalogue of individual test panels or products. Healthians therefore occupies a position between a consumer-facing digital health platform and a conventional diagnostics provider: the brand experience is digital and home-oriented, while the underlying services depend on laboratory infrastructure, sample logistics, medical processes, and regulatory compliance. Healthians attracted early backing from Healthstart in 2015, followed later that year by investment from YouWeCan, the venture investment firm associated with cricketer Yuvraj Singh. In 2016, Japanese venture investor BeeNext participated in a Series A round. The company later raised Series B financing in November 2019, including investment from Japan-based DG Incubation and DG Daiwa Ventures. Other investors identified in the available material include Beenos Partners, Mistetoe, Trifecta Capital, HealthStart, Asuka Holdings, and Kotak Private Equity. The reference material reports cumulative funding of $22.8 million and says that Healthians announced plans in 2022 to raise an additional $54 million led by WestBridge Capital; these figures describe reported financing activity rather than public-market performance. Healthians also became the subject of a regulatory controversy concerning COVID-19 sample collection. A complaint by Dr. Rohit Jain alleged that the service had been permitted to collect samples from COVID-19 patients without the appropriate licence. In an affidavit filed with the Delhi High Court on 26 October, Gurugram Police stated that Healthians had not performed COVID-19 tests before 15 April 2021 and had instead collected samples under a memorandum of understanding with laboratories approved by the National Accreditation Board for Testing and Calibration Laboratories and the Indian Council of Medical Research. The affidavit also stated that the company held a registration certificate under the Clinical Establishments Act, 2010. The available material does not establish a final finding of wrongdoing. As of 2025, Healthians was described as being led by Nishant Singhal, identified as chief executive officer and a board member. The company’s core proposition remains the delivery of convenient, digitally ordered diagnostic services through home collection and a distributed laboratory network in India.

Healthians was incorporated in India in 2015 as a subsidiary of Expedient Healthcare and was founded by Deepak Sahni. From its beginning, the company pursued a home-collection model for diagnostic testing, using digital ordering and appointments to connect customers with sample-collection personnel and laboratories. Its first laboratory was established in Gurugram, Haryana, where the company is headquartered. The business received seed funding from Healthstart in 2015. It also attracted investment from YouWeCan, a venture-capital firm associated with cricketer Yuvraj Singh, during the same year. In 2016, Japanese venture fund BeeNext invested through a Series A round. These early investments supported the development of the company’s technology, laboratory capabilities, and collection operations. Healthians expanded its geographic reach through a network of laboratories and home-collection services. Reference material describes the company as operating in more than 250 cities and maintaining 20 laboratories across India. Its service proposition is based on convenience: customers can arrange diagnostic testing without visiting a conventional collection centre, while Healthians manages the collection process and laboratory workflow. The available sources identify routine diagnostics and health-check services as the central scope of the brand, but do not document every test category or package. In November 2019, Healthians reportedly raised up to $14 million in Series B funding. Approximately $12 million of that round was attributed to Japan-based DG Incubation and DG Daiwa Ventures. Other named investors include Beenos Partners, Mistetoe, Trifecta Capital, HealthStart, Asuka Holdings, and Kotak Private Equity. The available reference material reports total funding of $22.8 million. In 2022, Healthians announced plans to raise another $54 million in a round led by WestBridge Capital; the material does not confirm whether the proposed amount was fully closed. The company became involved in a COVID-19 regulatory dispute. Dr. Rohit Jain filed a complaint alleging that Healthians had been allowed to collect samples from COVID-19 patients without a proper licence. On 26 October, Gurugram Police filed an affidavit with the Delhi High Court stating that Healthians had not performed COVID-19 testing before 15 April 2021. According to the affidavit, its role was sample collection under a memorandum of understanding with laboratories approved by NABL and ICMR, and the company held a registration certificate under the Clinical Establishments Act, 2010. The available reference does not provide a definitive judicial finding that Healthians violated the law. By 2025, Nishant Singhal was identified as the company’s chief executive officer and a board member. Healthians remained an active Indian health-tech and diagnostics brand, with its identity centred on at-home sample collection, online service access, and a broad laboratory and city network.

1. 2025Leadership under Nishant Singhal

   Nishant Singhal was identified as chief executive officer and a board member.

   Source
2. 2022Proposed additional financing

   Healthians announced plans to raise an additional $54 million led by WestBridge Capital.

   Source
3. 2019Series B financing

   Healthians reportedly raised up to $14 million in Series B financing, including $12 million from DG Incubation and DG Daiwa Ventures.

   Source
4. 2016Series A financing

   BeeNext invested in Healthians through a Series A funding round.

   Source
5. 2015Incorporation and launch

   Healthians was incorporated as a subsidiary of Expedient Healthcare and founded by Deepak Sahni. Its first laboratory was established in Gurugram.

   Source
6. 2015Seed and early strategic investment

   Healthstart provided seed funding, followed by investment from YouWeCan.

   Source

A consumer-focused Indian diagnostics platform combining online booking, home sample collection, and laboratory testing.

• At-home diagnostic sample collectionDiagnostic service2015

  Healthians enables customers to arrange diagnostic sample collection at home through its digital service. Collected specimens are processed through the company’s laboratory network or partner laboratories, reducing the need for customers to travel to a diagnostic centre. The available sources describe this home-collection model as the central service proposition, without listing every specimen type or test included.

• Health check-up packagesPreventive healthcare

  The brand offers consumer-oriented health screening and diagnostic packages intended to support routine testing and preventive care. These packages are accessed through the company’s online service and may use home collection, although the reference material does not specify the full package catalogue or medical inclusions.

• Laboratory diagnostic testingPathology and diagnostics2015

  Healthians operates a laboratory and collection network supporting routine diagnostic testing in India. The reference material identifies 20 laboratories and service coverage in more than 250 cities as of the cited account. Specific laboratory departments, assays, and accreditation details are not fully documented in the supplied sources.

• 2015Adoption of a home-collection diagnostics modelStrategy

  Healthians was established as a digital health and diagnostics business intended to make testing more convenient for consumers.

  What changed. The company built an online ordering and appointment model linked to at-home sample collection and laboratory processing.

  Aftermath. The model became the defining basis of the brand’s service proposition and supported expansion across Indian cities.

  Source

• 2021COVID-19 sample-collection licensing disputeControversy

  Dr. Rohit Jain complained that Healthians had allegedly been allowed to collect COVID-19 patient samples without a proper licence. In an affidavit to the Delhi High Court, Gurugram Police stated that Healthians had not conducted COVID-19 tests before 15 April 2021, had collected samples under an agreement with NABL- and ICMR-approved laboratories, and possessed registration under the Clinical Establishments Act, 2010. The supplied material does not establish a final finding of wrongdoing.

  Source

• 2022Healthians announces plans for additional funding

  The company announced that it planned to raise a further $54 million in financing led by WestBridge Capital.

  Other
  Source
• 2019Healthians raises Series B funding

  Healthians reportedly raised up to $14 million in Series B financing in November 2019, including $12 million from DG Incubation and DG Daiwa Ventures.

  Other
  Source

1. Healthians